Tocqueville Asset Management L.P. Trims Holdings in Colgate-Palmolive (NYSE:CL)

Tocqueville Asset Management L.P. lessened its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 4.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 575,090 shares of the company's stock after selling 29,379 shares during the quarter. Colgate-Palmolive makes up about 0.8% of Tocqueville Asset Management L.P.'s investment portfolio, making the stock its 25th largest position. Tocqueville Asset Management L.P. owned about 0.07% of Colgate-Palmolive worth $52,281,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Swedbank AB lifted its position in shares of Colgate-Palmolive by 1.4% in the third quarter. Swedbank AB now owns 2,950,059 shares of the company's stock worth $306,246,000 after buying an additional 40,324 shares in the last quarter. OneDigital Investment Advisors LLC grew its stake in shares of Colgate-Palmolive by 23.8% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 14,829 shares of the company's stock worth $1,539,000 after buying an additional 2,847 shares in the last quarter. Empowered Funds LLC increased its holdings in shares of Colgate-Palmolive by 22.5% in the 3rd quarter. Empowered Funds LLC now owns 69,602 shares of the company's stock worth $7,225,000 after buying an additional 12,797 shares during the last quarter. Natixis Advisors LLC raised its position in shares of Colgate-Palmolive by 15.5% during the 3rd quarter. Natixis Advisors LLC now owns 386,681 shares of the company's stock valued at $40,141,000 after buying an additional 51,991 shares in the last quarter. Finally, Adero Partners LLC lifted its holdings in shares of Colgate-Palmolive by 9.6% in the 3rd quarter. Adero Partners LLC now owns 3,141 shares of the company's stock valued at $326,000 after acquiring an additional 275 shares during the last quarter. Institutional investors own 80.41% of the company's stock.

Remove Ads

Colgate-Palmolive Stock Up 0.0 %

Shares of NYSE:CL traded up $0.02 during trading on Friday, reaching $90.30. The stock had a trading volume of 8,950,637 shares, compared to its average volume of 4,222,165. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The firm's 50-day simple moving average is $89.25 and its 200 day simple moving average is $94.38. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The company has a market capitalization of $73.28 billion, a P/E ratio of 25.65, a PEG ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the business posted $0.87 earnings per share. As a group, research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive declared that its Board of Directors has initiated a share buyback plan on Thursday, March 20th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the company to buy up to 6.8% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's management believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be given a $0.52 dividend. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a dividend yield of 2.30%. The ex-dividend date is Thursday, April 17th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 56.82%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on CL. TD Cowen dropped their target price on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the stock an "overweight" rating in a research note on Friday, March 14th. UBS Group reduced their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research note on Monday, February 3rd. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research note on Monday, January 6th. Finally, Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $101.72.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.